Zone7
AI injury-risk prediction and load planning for elite team sports.
Acquired — still operating
Acquired by Svexa in February 2024; sold as part of the Svexa human-performance suite.
About
Zone7 is an AI platform founded in 2017 in Palo Alto by Tal Brown and Eyal Eliakim that predicts athlete injury risk by analyzing wearable data, medical profiles, and training-load history. It was the first widely cited company claiming AI can forecast injuries before they happen, and it raised $8M in Series A funding in 2021 led by Blumberg Capital (over $10M total), with athlete investors including Manchester United's Phil Jones and Kristaps Porzingis.
The device-agnostic platform is used by elite organizations across the EPL, MLS, NFL, La Liga, Serie A, and Premiership Rugby, plus hospitals for workforce management. In February 2024, Svexa acquired Zone7 and now offers it as the team-sports module of its human-performance suite. Injury-prediction accuracy claims remain provider-reported rather than independently benchmarked, so treat risk scores as decision support, not medical diagnosis.
What it can do
- AI injury-risk scoring per athlete
- Training load simulation and planning
- Device-agnostic data ingestion
- Burnout and fatigue detection
- Medical-profile integration
Setup
Engage via Svexa; connect wearable and medical data sources for model calibration.
Prerequisites
Wearable and medical data feeds; medical-staff oversight for risk decisions.
Use cases
Works with
Trust score — 7/10
Scored 7/10 (verified tier, metrics-v1). Evidence: Founded 2017 Palo Alto; $8M Series A (2021) led by Blumberg Capital, >$10M total raised; Clients across EPL, MLS, NFL, La Liga, Serie A, PRO14, Premiership Rugby (provider-claimed); Acquired by Svexa in February 2024; now the team-sports module of Svexa's suite. Manual review: injury-prediction accuracy is vendor-reported, not independently benchmarked; decision support, not diagnosis. License: Proprietary AI platform; sold via Svexa enterprise engagements..
How the trust score is built
Full methodology →- Adoption · stars/downloads, log-scaled vs peers
- 7.0/10
- Maintenance · recency, releases, issue load
- 7.0/10
- Openness · license + docs
- 3.0/10
- Manual review · sanity read + red-flag check
- 7.0/10
- · Founded 2017 Palo Alto; $8M Series A (2021) led by Blumberg Capital, >$10M total raised
- · Clients across EPL, MLS, NFL, La Liga, Serie A, PRO14, Premiership Rugby (provider-claimed)
- · Acquired by Svexa in February 2024; now the team-sports module of Svexa's suite
- · manual review: injury-prediction accuracy is vendor-reported, not independently benchmarked; decision support, not diagnosis
Sources
Every fact above was checked against these sources. Where a claim comes from the provider and couldn't be independently verified, the text says so.